Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 03:05:49 2026-08-24 am EDT			5-day change	1st Jan Change
59.45 ^EUR	-0.59%		+3.19%	-5.83%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.57B		BBB
ELI LILLY AND COMPANY	1,119B		A
JOHNSON & JOHNSON	651B	-	BBB	-	-
ABBVIE INC.	468B		AA		-
ROCHE HOLDING AG	374B		AA
NOVARTIS AG	302B		AAA
ASTRAZENECA PLC	259B		A
AMGEN INC.	238B		A
NOVO NORDISK A/S	208B		A
GILEAD SCIENCES, INC.	181B		AA
PFIZER INC.	160B		A
VERTEX PHARMACEUTICALS INCORPORATED	139B		AA
BRISTOL-MYERS SQUIBB COMPANY	137B		A
SANOFI	110B		AA
GSK PLC	105B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	72.56B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	57.89B		AA
BAYER AG	55.1B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	46.76B		AA
HALEON PLC	43.6B		AA
Average	236.52B		AA
Weighted average by Cap.			AA